Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest Clinical Trials & Medical Discoveries

18 Oct, 2018, 05:01 BST The Impact of Fragility Fractures due to Osteoporosis is Being Ignored

- New survey reveals that 61 per cent of women over 60 have little or no knowledge of osteoporosis,[1] despite the fact that one in three...


17 Oct, 2018, 13:00 BST Daiichi Sankyo Submits Application in Japan for FLT3 Inhibitor Quizartinib for Treatment of Patients with Relapsed/Refractory FLT3-ITD AML

-- Submission based on results of pivotal phase 3 QuANTUM-R study and open-label phase 2 study in Japan of quizartinib in patients with...


17 Oct, 2018, 12:00 BST Alkermes Highlights Ongoing Commitment to Research and Innovation in Depression and Schizophrenia at 2018 Psych Congress

Alkermes plc (Nasdaq: ALKS) today announced the presentation of 10 posters at the upcoming 31st Annual Psych Congress (Psych Congress) in Orlando,...


17 Oct, 2018, 06:00 BST Pharming Reports Positive Data From First Investigator-initiated Study of rhC1-Inhibitor (RUCONEST®) in Contrast-induced Nephropathy

Primary Endpoint was met, with rhC1INH treatment reducing neutrophil gelatinase-associated lipocalin (NGAL), a widely recognized marker of acute...


16 Oct, 2018, 20:22 BST UPDATED -- JHL Biotech Announces China Approves Phase I and Phase III Clinical Trial Application for Bevacizumab Biosimilar to Treat Cancer

JHL Biotech announced that the National Medical Products Administration of the PRC (NMPA) has approved JHL's Phase I and Phase III Clinical Trial...


16 Oct, 2018, 17:25 BST HBKU Researcher Competes in Season 10 of Stars of Science

Breaking new ground for early Parkinson's diagnostics, Qatar-based hopeful qualifies among top nine contestants in Arab world's leading...


16 Oct, 2018, 07:58 BST BioInvent to Expand Pipeline With New Development Programs in Solid Cancer

Aim is to add three clinical programs in solid cancer starting H1 2019 BioInvent Capital Markets Day in Stockholm on December 10 to provide...


15 Oct, 2018, 14:00 BST JHL Biotech Announces China Approves Phase I and Phase III Clinical Trial Application for Bevacizumab Biosimilar to Treat Cancer

JHL Biotech announced today that the National Medical Products Administration of the PRC (NMPA) has approved JHL's Phase I and Phase III Clinical...


15 Oct, 2018, 12:00 BST Bluegrass Vascular Announces Enrollment Completion Of International Post-Market SAVE Registry With Early Positive Results

IDE study, SAVE-US, expands patient enrollment and further demonstrates positive trends Bluegrass Vascular Technologies (Bluegrass...


15 Oct, 2018, 11:40 BST Sysmex Inostics' OncoBEAM™ Liquid Biopsy Technology Demonstrates Utility for Clinical Management of Melanoma Patients Undergoing Treatment With Targeted Therapy and Immune Checkpoint Inhibitors

Sysmex Inostics, a pioneer in blood-based circulating tumor DNA (ctDNA) analysis and molecular diagnostics for oncology, is pleased to announce...


15 Oct, 2018, 06:20 BST Targovax Reports Encouraging Disease-free Survival (DFS) Data From Tg01 Trial in Resected Pancreatic Cancer

Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard to treat solid tumors, today...


12 Oct, 2018, 15:17 BST Micro Interventional Devices, Inc.™ Successfully Treats First-in-Human Patient with Percutaneous MIA™, Minimally Invasive Annuloplasty Technology

Clinical Enrollment in STTAR (The Study of Transcatheter Tricuspid Annular Repair) Continues in Europe Micro Interventional Devices, Inc.™...


11 Oct, 2018, 17:26 BST Better Diet Quality is Associated With Better Brain Health

A recent observational study, which was carried out between 2005 and 2015 with 4,213 participants from the Rotterdam Study, links a healthy diet...


11 Oct, 2018, 14:56 BST Frost & Sullivan Publishes Immediate Update Report on Kadimastem Ltd.: World's First successful transplant of embryonic stem cells in ALS patients

Due to a higher probability of success in current clinical trials (results due in mid-2019), target price increased to NIS 1.12 Equity Research is...


11 Oct, 2018, 12:30 BST Endo Presents Data on the Perception and Measurement of Cellulite Severity at the American Society for Dermatologic Surgery (ASDS) Annual Meeting

Endo International plc (NASDAQ: ENDP) today announced that data regarding the evaluation and rating of cellulite severity will be presented at the...


11 Oct, 2018, 09:20 BST Arix Bioscience plc : Pharmaxis Releases Positive Results of Phase 1 Clinical Trial for LOXL2 Inhibitor Compound

Arix Bioscience plc ("Arix") (LSE: ARIX), a global healthcare and life science company supporting medical innovation, is pleased to note that its...


11 Oct, 2018, 06:34 BST Targovax Key Opinion Leader Symposium on Oncolytic Viruses in New York City Today, 11 October, 2018

Symposium faculty to include Dmitriy Zamarin, MD, PhD, and Alexander N. Shoushtari, MD, medical oncologists from Memorial Sloan Kettering Cancer...


10 Oct, 2018, 13:24 BST Conjoined Twins From Mali Given New Lease of Life at Sidra Medicine, Qatar

Doctors at Qatar's first specialist women's and children's hospital Sidra Medicine have successfully separated conjoined twins, marking a first...


10 Oct, 2018, 10:00 BST Cantrixil Phase I Study Progresses To Next Stage

Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce the successful...


10 Oct, 2018, 08:00 BST Gedeon Richter Plc.: Cariprazine Shows Favorable Safety Parameters and Efficacy in Reducing Schizophrenia Negative Symptoms Compared to Aripiprazole

On 6-9 October 2018, during the 31th congress of European College of Neuropsychopharmacology (ECNP) in Barcelona, Spain, new post hoc analysis of...


10 Oct, 2018, 07:41 BST NeuroVive Receives KL1333 Clinical Trial Regulatory Approval

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that it has received approval of its clinical trial application...


09 Oct, 2018, 21:37 BST New NCCN Breast Cancer Guidelines Elevate Oncotype DX Breast Recurrence Score® as the Only Preferred Multi-gene Test to Predict Chemotherapy Treatment

Updated NCCN Guidelines Underscore the Unique Advantage of the Oncotype DX® Test in Predicting Chemotherapy Benefit Genomic Health, Inc....


09 Oct, 2018, 08:16 BST Oblique Therapeutics Present Tumor Growth Inhibition and Treg-lowering Data for OT-1096 in Humanized Mouse TNBC Model at Oncology Congress ESMO

Oblique Therapeutics, a biotech focused on new medicines for severe diseases with large unmet medical needs, today announced that it will present...


09 Oct, 2018, 08:16 BST BerGenBio to Present Interim Phase II Clinical, Preclinical and Biomarker Data With Selective AXL Inhibitor Bemcentinib at ESMO

BerGenBio ASA (OSE:BGBIO) announces that the company and its collaborators will present interim clinical and biomarker data from its Phase II...


09 Oct, 2018, 08:00 BST Strekin AG Announces the Publication of Key in vivo Data on Mechanisms of STR001 in the Treatment of Sensorineural Hearing Loss

Strekin AG, a clinical-stage biopharmaceutical company, today announced the publication of key scientific data on efficacy and mechanism of...